Factors Associated With Off-Label Use of Drug-Eluting Stents in Patients With ST-Elevation Myocardial Infarction

American Journal of Cardiology

Volumn 101, Issue 3, 2008, Pages 286-292

  Ting, Henry H ^a   Roe, Matthew T ^b   Gersh, Bernard J ^a   Spertus, John A ^c   Rumsfeld, John S ^d   Ou, Fang Shu ^b   Kao, John ^e   Long, Kirsten Hall ^a   Holmes Jr , David R ^a   Peterson, Eric D ^b  

^a MAYO CLINIC   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HEALTH INSURANCE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DRUG LABELING; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 38549162280     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.09.084     Document Type: Article

References (30)

1. Morice M.-C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnar F., Falotico R., and RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
3. Park S.-J., Shim W.H., Ho D.S., Raizner A.E., Park S.-W., Hong M.-K., Lee C.W., Choi D., Jang Y., Lam R., Weissman N.J., and Mintz G.S. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 348 (2003) 1537-1545
4. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
5. Maisel W.H. Unanswered questions-drug-eluting stents and the risk of late thrombosis. N Engl J Med 356 (2007) 981-984
6. Farb A., and Boam A.B. Stent thrombosis redux-the FDA perspective. N Engl J Med 356 (2007) 984-987
7. Curfman G.D., Morrissey S., Jarcho J.A., and Drazen J.M. Drug-eluting coronary stents-promise and uncertainty. N Engl J Med 356 (2007) 1059-1060
8. Beohar N., Davidson C.J., Kip K.E., Goodreau L., Vlachos H.A., Meyers S.N., Benzuly K.H., Flaherty J.D., Ricciardi M.J., Bennett C.L., and Williams D.O. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 297 (2007) 1992-2000
9. Spaulding C., Henry P., Teiger E., Beatt K., Bramucci E., Carrie D., Slama M.S., Merkely B., Erglis A., Margheri M., et al., TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355 (2006) 1093-1104
10. Laarman G.J., Suttorp M.J., Dirksen M.T., van Heerebeek L., Kiemeneij F., Slagboom T., van der Wieken L.R., Tijssen J.G.P., Rensing B.J., and Patterson M. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 355 (2006) 1105-1113
11. Pasceri V., Patti G., Speciale G., Pristipino C., Richichi G., and Di Sciascio G. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 153 (2007) 749-754
12. Rao S.V., Shaw R.E., Brindis R.G., Klein L.W., Weintraub W.S., Krone R.J., and Peterson E.D. Patterns and outcomes of drug-eluting coronary stent use in clinical practice. Am Heart J 152 (2006) 321-326
13. Calvin J.E., Roe M.T., Chen A.Y., Mehta R.H., Brogan Jr. G.X., DeLong E.R., Fintel D.J., Gibler W.B., Ohman E.M., Smith Jr. S.C., and Peterson E.D. Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 145 (2006) 739-748
14. Every N.R., Cannon C.P., Granger C., Moliterno D.J., Aguirre F.V., Talley J.D., Booth J., Sapp S., and Ferguson J.J.A.-. Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE registry. J Amer Coll Cardiol 32 (1998) 387-392
15. Kandzari D.E., Roe M.T., Ohman E.M., Milford-Beland S., Chen A.Y., Lytle B.L., Cohen D.J., Smith S.C., Harrington R.A., Gibler W.B., and Peterson E.D. Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes. Am J Cardiol 96 (2005) 750-755
16. Lurie N., and Dubowitz T. Health disparities and access to health. JAMA 297 (2007) 1118-1121
17. Rahimi A.R., Spertus J.A., Reid K.J., Bernheim S.M., and Krumholz H.M. Financial barriers to health care and outcomes after acute myocardial infarction. JAMA 297 (2007) 1063-1072
18. Sada M.J., French W.J., Carlisle D.M., Chandra N.C., Gore J.M., and Rogers W.J. Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States. J Am Coll Cardiol 31 (1998) 1474-1480
19. Weintraub W.S., McKay C.R., Riner R.N., Ellis S.G., Frommer P.L., Carmichael D.B., Hammermeister K.E., Effros M.N., Bost J.E., and Bodycombe D.P. For the American College of Cardiology Database Committee. The American College of Cardiology national database: progress and challenges. J Am Coll Cardiol 29 (1997) 459-465
20. Brindis R.G., Fitzgerald S., Anderson H.V., Shaw R.E., Weintraub W.S., and Williams J.F. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol 37 (2001) 2240-2245
21. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
22. Luscher T.F., Steffel J., Eberli F.R., Joner M., Nakazawa G., Tanner F.C., and Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115 (2007) 1051-1058
23. Serruys P.W., and Daemen J. Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation 115 (2007) 1433-1439
24. Camenzind E., Steg P.G., and Wijns W. A cause for concern. Circulation 115 (2007) 1440-1455
25. Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 989-997
26. Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.-C., Colombo A., Schampaert E., Grube E., Kirtane A.J., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
27. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., Wallentin L., and SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
28. Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Menichelli M., Sabate M., Suttorp M.J., Baumgart D., et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
29. Mauri L., Hsieh W.-h., Massaro J.M., Ho K.K.L., D'Agostino R., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
30. Spertus J.A., Kettelkamp R., Vance C., Decker C., Jones P.G., Rumsfeld J.S., Messenger J.C., Khanal S., Peterson E.D., Bach R.G., Krumholz H.M., and Cohen D.J. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry. Circulation 113 (2006) 2803-2809